General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), GlaxoSmithKline(MODEST), Novo Nordisk Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(MODEST)

View Full Disclosure